UMP Healthcare Holdings Limited
HKEX:0722.HK
0.43 (HKD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 748.489 | 727.75 | 666.201 | 617.164 | 558.814 | 567.377 | 585.63 | 514.023 | 456.02 | 401.037 | 355.453 | 318.906 |
Cost of Revenue
| 56.238 | 225.064 | 202.251 | 160.887 | 171.774 | 30.624 | 23.73 | 20.5 | 17.585 | 15.898 | 58.365 | 51.356 |
Gross Profit
| 692.251 | 502.686 | 463.95 | 456.277 | 387.04 | 536.753 | 561.9 | 493.523 | 438.435 | 385.139 | 297.088 | 267.55 |
Gross Profit Ratio
| 0.925 | 0.691 | 0.696 | 0.739 | 0.693 | 0.946 | 0.959 | 0.96 | 0.961 | 0.96 | 0.836 | 0.839 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 269.397 | 255.396 | 238.035 | 217.498 | 216.653 | 229.321 | 309.264 | 328.582 | 293.789 | 257.52 | 213.497 | 196.22 |
Selling & Marketing Expenses
| 16.623 | 14.047 | 11.076 | 10.275 | -2.833 | 0 | 0 | 0 | 0 | 0 | 18.518 | 15.778 |
SG&A
| 269.397 | 269.443 | 249.111 | 227.773 | 213.82 | 229.321 | 309.264 | 328.582 | 293.789 | 257.52 | 232.015 | 211.998 |
Other Expenses
| 327.454 | -63.796 | -62.928 | -70.899 | -23.412 | -78.726 | -31.589 | -31.241 | -42.441 | -17.893 | 0 | 0 |
Operating Expenses
| 596.851 | 441.069 | 377.783 | 366.064 | 320.512 | 447.562 | 490.968 | 442.527 | 374.548 | 326.019 | 248.1 | 226.818 |
Operating Income
| 95.4 | 69.617 | 75.813 | 103.729 | 52.167 | 10.717 | 70.932 | 100.715 | 64.857 | 63.739 | 45.137 | 38.094 |
Operating Income Ratio
| 0.127 | 0.096 | 0.114 | 0.168 | 0.093 | 0.019 | 0.121 | 0.196 | 0.142 | 0.159 | 0.127 | 0.119 |
Total Other Income Expenses Net
| -54.776 | -5.252 | 10.167 | -13.372 | 21.239 | 23.558 | -22.427 | 6.098 | -49.633 | -11.34 | 4.062 | 2.811 |
Income Before Tax
| 40.624 | 64.365 | 85.98 | 90.357 | 73.406 | 34.275 | 48.505 | 57.094 | 14.254 | 47.78 | 49.199 | 40.905 |
Income Before Tax Ratio
| 0.054 | 0.088 | 0.129 | 0.146 | 0.131 | 0.06 | 0.083 | 0.111 | 0.031 | 0.119 | 0.138 | 0.128 |
Income Tax Expense
| 5.407 | 8.63 | 11.946 | 19.78 | 13.096 | 14.726 | 11.003 | 8.85 | 7.372 | 6.92 | 6.653 | 5.894 |
Net Income
| 40.643 | 60.452 | 72.168 | 73.874 | 58.915 | 12.798 | 37.555 | 44.085 | 6.676 | 41.392 | 41.537 | 33.601 |
Net Income Ratio
| 0.054 | 0.083 | 0.108 | 0.12 | 0.105 | 0.023 | 0.064 | 0.086 | 0.015 | 0.103 | 0.117 | 0.105 |
EPS
| 0.051 | 0.077 | 0.073 | 0.097 | 0.078 | 0.017 | 0.05 | 0.06 | 0.01 | 0.075 | 0 | 0 |
EPS Diluted
| 0.051 | 0.077 | 0.073 | 0.097 | 0.078 | 0.017 | 0.05 | 0.059 | 0.01 | 0.075 | 0 | 0 |
EBITDA
| 161.354 | 103.821 | 101.734 | 127.308 | 75.45 | 97.244 | 90.111 | 44.83 | 73.498 | 64.587 | 47.584 | 40.452 |
EBITDA Ratio
| 0.216 | 0.143 | 0.153 | 0.206 | 0.135 | 0.171 | 0.154 | 0.087 | 0.161 | 0.161 | 0.134 | 0.127 |